Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | SSTR5 | P35346 | 9/20 | 0.47 |
| ▸ | USP2 | O75604 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | PKM | P14618 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | UBE2N | P61088 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3137920 | 0.92 | ALDH1A1 (0.46) | ALDH1A1SSTR5USP2SMN1; SMN2PKM | |
| SCHEMBL3128617 | 0.92 | SSTR5 (0.47) | ALDH1A1SSTR5USP2SMN1; SMN2PKM | |
| SCHEMBL3133924 | 0.92 | USP2 (0.44) | ALDH1A1SSTR5USP2SMN1; SMN2PKM | |
| SCHEMBL3137260 | 0.92 | USP2 (0.44) | ALDH1A1SSTR5USP2SMN1; SMN2PKM | |
| SCHEMBL3135069 | 0.90 | SSTR5 (0.57) | ALDH1A1SSTR5KCNH2 | |
| SCHEMBL3133541 | 0.90 | SSTR5 (0.50) | ALDH1A1SSTR5USP2SMN1; SMN2PKM | |
| SCHEMBL3128281 | 0.90 | USP2 (0.47) | ALDH1A1USP2SMN1; SMN2PKMMAPK1 | |
| SCHEMBL3134311 | 0.89 | SSTR5 (0.43) | ALDH1A1SSTR5USP2SMN1; SMN2PKM | |
| SCHEMBL3128667 | 0.88 | SSTR5 (0.48) | ALDH1A1SSTR5USP2SMN1; SMN2PKM | |
| SCHEMBL3093309 | 0.88 | SSTR5 (0.58) | SSTR5USP2SMN1; SMN2PKMMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2142528-B1 | 1-(1-BENZYLPIPERIDIN-4-YL)BENZIMIDAZ0LE -5-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS | HOFFMANN LA ROCHE (CH) | 2010-07-07 | — | — | EP | claimed |